Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

FesariusTherapeutics secures $20M in an oversubscribed Series A round, led by Jefferson Life Sciences, to advance its innovative DermiSphere technology.

PRIVATEJun 10, 2026•2 months ago

Amount Raised

$20 Million

Round Type

Series A

New YorkManufacturingBiotechnologyHealth CareMedicalMedical Device

Investors

American Society Of Plastic SurgeonsEmpire State Development's Ny VenturesJohnson & JohnsonJefferson Life Sciences

Description

FesariusTherapeutics has successfully closed a $20 million Series A financing round. The round was led by Jefferson Life Sciences, alongside investors like Johnson & Johnson Innovation and NY Ventures. This funding will help accelerate the company's commercial infrastructure and support clinical trials for its flagship product, DermiSphere™. The investment marks a significant milestone for Fesarius as it builds commercial momentum in U.S

Company Information

Company

FesariusTherapeutics

Location

New York, New York, United States

About

FesariusTherapeutics is a commercial-stage medical technology company reimagining dermal repair. Its flagship product, DermiSphere™, is the first hydrogel Dermal Regeneration Template on the U.S. market, cleared by the FDA for managing various wound types. The company aims to transform wound care through innovative solutions that improve patient outcomes. With a focus on advancing its technologies, Fesarius is poised for significant growth in the medical device sector.

Related People

Suggested for you
2 contacts
Verified contactsTim O., Vice President of Sales & Marketing hidden hidden
Predictive Intelligence
Strategic

ML-powered predictions for FesariusTherapeutics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.